Robert W. Duggan - 17 Nov 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Ken Stratton
Issuer symbol
PLSE
Transactions as of
17 Nov 2023
Net transactions value
+$123,470
Form type
4
Filing time
20 Nov 2023, 20:56:32 UTC
Previous filing
09 Nov 2023
Next filing
30 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $1,470 +241 +0% $6.10 36,246,797 17 Nov 2023 Direct
transaction PLSE Common Stock Purchase $60,900 +10,000 +0.03% $6.09 36,256,797 17 Nov 2023 Direct
transaction PLSE Common Stock Purchase $61,100 +10,000 +0.03% $6.11 36,266,797 17 Nov 2023 Direct
holding PLSE Common Stock 492,069 17 Nov 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.